$COST
COSTCO WHOLESALE CORP /NEW Stock $cost

$cost Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000090983223000065 Filed on December 20, 2023

Income Statement

Concept	2023 Q4
Revenue	$57.80B
YoY Change	6.18%
Cost Of Revenue	$50.46B
YoY Change	5.63%
Gross Profit	$7.342B
YoY Change	10.11%
Gross Profit Margin	12.7%
Selling, General & Admin	$5.358B
YoY Change	8.97%
% of Gross Profit	72.98%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$501.0M
YoY Change	12.08%
% of Gross Profit	6.82%
Operating Expenses	$5.358B
YoY Change	8.97%
Operating Profit	$1.984B
YoY Change	13.31%
Interest Expense	$38.00M
YoY Change	100.0%
% of Operating Profit	1.92%
Other Income/Expense, Net	$3.000M
YoY Change	-62.5%
Pretax Income	$2.106B
YoY Change	18.98%
Income Tax	$517.0M
% Of Pretax Income	24.55%
Net Earnings	$1.589B
YoY Change	16.5%
Net Earnings / Revenue	2.75%
Basic Earnings Per Share	$3.58
Diluted Earnings Per Share	$3.58
COMMON SHARES
Basic Shares Outstanding	442.7M shares
Diluted Shares Outstanding	444.4M shares

Balance Sheet

Concept	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$17.86B
YoY Change	53.04%
Cash & Equivalents	$17.01B
Short-Term Investments	$853.0M
Other Short-Term Assets	$1.673B
YoY Change	4.96%
Inventory	$18.00B
Prepaid Expenses
Receivables	$2.542B
Other Receivables	$0.00
Total Short-Term Assets	$40.08B
YoY Change	17.36%
LONG-TERM ASSETS
Property, Plant & Equipment	$27.17B
YoY Change	-2.73%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$3.803B
YoY Change	-3.62%
Total Long-Term Assets	$33.64B
YoY Change	5.54%
TOTAL ASSETS
Total Short-Term Assets	$40.08B
Total Long-Term Assets	$33.64B
Total Assets	$73.72B
YoY Change	11.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$20.36B
YoY Change	10.95%
Accrued Expenses	$2.207B
YoY Change	-64.83%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00
YoY Change
Long-Term Debt Due	$1.080B
YoY Change	1421.13%
Total Short-Term Liabilities	$36.77B
YoY Change	11.19%
LONG-TERM LIABILITIES
Long-Term Debt	$5.866B
YoY Change	-9.36%
Other Long-Term Liabilities	$2.541B
YoY Change	-49.3%
Total Long-Term Liabilities	$8.407B
YoY Change	-26.79%
TOTAL LIABILITIES
Total Short-Term Liabilities	$36.77B
Total Long-Term Liabilities	$8.407B
Total Liabilities	$47.58B
YoY Change	6.78%
SHAREHOLDERS EQUITY
Retained Earnings	$20.50B
YoY Change	24.9%
Common Stock	$7.491B
YoY Change	7.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$26.15B
YoY Change
Total Liabilities & Shareholders Equity	$73.72B
YoY Change	11.66%

Cashflow Statement

Concept	2023 Q4
OPERATING ACTIVITIES
Net Income	$1.589B
YoY Change	16.5%
Depreciation, Depletion And Amortization	$501.0M
YoY Change	12.08%
Cash From Operating Activities	$4.651B
YoY Change	78.2%
INVESTING ACTIVITIES
Capital Expenditures	$1.040B
YoY Change	-1.61%
Acquisitions
YoY Change
Other Investing Activities	$4.000M
YoY Change	-80.95%
Cash From Investing Activities	-$366.0M
YoY Change	-65.37%
FINANCING ACTIVITIES
Cash Dividend Paid	$905.0M
YoY Change	126.25%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$974.0M
YoY Change	12.86%
NET CHANGE
Cash From Operating Activities	$4.651B
Cash From Investing Activities	-$366.0M
Cash From Financing Activities	-$974.0M
Net Change In Cash	$3.311B
YoY Change	407.04%
FREE CASH FLOW
Cash From Operating Activities	$4.651B
Capital Expenditures	$1.040B
Free Cash Flow	$3.611B
YoY Change	132.52%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.005
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.005
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.005
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.005
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	443787000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	442793000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	443787000	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	442793000	shares
CY2023Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2106000000	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1770000000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1080000000	usd
CY2023Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	1081000000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6188000000	usd
CY2023Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6254000000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	36768000000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	33583000000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	5866000000	usd
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	5377000000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2401000000	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2426000000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2541000000	usd
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2550000000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	47576000000	usd
CY2023Q3	us-gaap	Liabilities Liabilities	43936000000	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.005
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.005
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	443787000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	442793000	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	2000000	usd
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	2000000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	7489000000	usd
CY2023Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	7340000000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1843000000	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1805000000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	20499000000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	19521000000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	26147000000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	25058000000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	73723000000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	68994000000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	25058000000	usd
CY2023Q4	us-gaap	Profit Loss ProfitLoss	1589000000	usd
CY2023Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-38000000	usd
CY2023Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	446000000	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	292000000	usd
CY2023Q4	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	162000000	usd
CY2023Q4	us-gaap	Dividends Cash DividendsCash	454000000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	26147000000	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	20647000000	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	1364000000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-96000000	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	403000000	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	301000000	usd
CY2022Q4	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	141000000	usd
CY2022Q4	us-gaap	Dividends Cash DividendsCash	400000000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	21476000000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	1589000000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	1364000000	usd
CY2023Q4	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	501000000	usd
CY2022Q4	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	447000000	usd
CY2023Q4	cost	Operatingand Financing Lease Rightof Use Asset Amortization OperatingandFinancingLeaseRightofUseAssetAmortization	74000000	usd
CY2022Q4	cost	Operatingand Financing Lease Rightof Use Asset Amortization OperatingandFinancingLeaseRightofUseAssetAmortization	111000000	usd
CY2023Q4	us-gaap	Share Based Compensation ShareBasedCompensation	444000000	usd
CY2022Q4	us-gaap	Share Based Compensation ShareBasedCompensation	402000000	usd
CY2023Q4	cost	Impairment Of Assets And Other Non Cash Operating Activities Net ImpairmentOfAssetsAndOtherNonCashOperatingActivitiesNet	43000000	usd
CY2022Q4	cost	Impairment Of Assets And Other Non Cash Operating Activities Net ImpairmentOfAssetsAndOtherNonCashOperatingActivitiesNet	121000000	usd
CY2023Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1384000000	usd
CY2022Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	737000000	usd
CY2023Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2854000000	usd
CY2022Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	487000000	usd
CY2023Q4	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-530000000	usd
CY2022Q4	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	-415000000	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4651000000	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2610000000	usd
CY2023Q4	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	200000000	usd
CY2022Q4	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	253000000	usd
CY2023Q4	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	878000000	usd
CY2022Q4	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	274000000	usd
CY2023Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1040000000	usd
CY2022Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1057000000	usd
CY2023Q4	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	4000000	usd
CY2022Q4	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	21000000	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-366000000	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1057000000	usd
CY2023Q4	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	173000000	usd
CY2022Q4	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	77000000	usd
CY2023Q4	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	144000000	usd
CY2022Q4	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	29000000	usd
CY2023Q4	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	498000000	usd
CY2022Q4	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2023Q4	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	292000000	usd
CY2022Q4	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	301000000	usd
CY2023Q4	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	162000000	usd
CY2022Q4	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	141000000	usd
CY2023Q4	us-gaap	Payments Of Dividends PaymentsOfDividends	905000000	usd
CY2022Q4	us-gaap	Payments Of Dividends PaymentsOfDividends	400000000	usd
CY2023Q4	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	82000000	usd
CY2022Q4	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	60000000	usd
CY2023Q4	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-2000000	usd
CY2022Q4	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	87000000	usd
CY2023Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-974000000	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-863000000	usd
CY2023Q4	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	usd
CY2022Q4	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-37000000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3311000000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	653000000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13700000000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10203000000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17011000000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10856000000	usd
CY2023Q4	us-gaap	Interest Paid Net InterestPaidNet	52000000	usd
CY2022Q4	us-gaap	Interest Paid Net InterestPaidNet	52000000	usd
CY2023Q4	us-gaap	Income Taxes Paid IncomeTaxesPaid	210000000	usd
CY2022Q4	us-gaap	Income Taxes Paid IncomeTaxesPaid	214000000	usd
CY2023Q4	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	29000000	usd
CY2022Q4	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	49000000	usd
CY2023Q4	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	18000000	usd
CY2022Q4	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	68000000	usd
CY2023Q4	us-gaap	Number Of Stores NumberOfStores	870	warehouse
CY2023Q4	us-gaap	Fiscal Period FiscalPeriod	<div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fiscal Year End</span></div>The Company operates on a 52/53 week fiscal year basis, with the fiscal year ending on the Sunday closest to August 31. Fiscal 2024 is a 52-week year ending on September 1, 2024. References to the first quarter of 2024 and 2023 relate to the 12-week fiscal quarters ended November 26, 2023, and November 20, 2022.
CY2023Q4	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates and assumptions take into account historical and forward-looking factors that the Company believes are reasonable. Actual results could differ from those estimates and assumptions.</span></div>
CY2023Q4	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reclassification</span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reclassifications were made to the condensed consolidated statement of cash flows for the first twelve weeks of fiscal 2023 to conform with current year presentation.</span></div>
CY2023Q4	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	288000	shares
CY2023Q4	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	564.06
CY2023Q4	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	162000000	usd
CY2022Q4	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	285000	shares
CY2022Q4	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	495.94
CY2022Q4	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	141000000	usd
CY2023Q4	cost	Available For Sale Securities And Held To Maturity Securities At Cost Basis AvailableForSaleSecuritiesAndHeldToMaturitySecuritiesAtCostBasis	873000000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	20000000	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	853000000	usd
CY2023Q3	cost	Available For Sale Securities And Held To Maturity Securities At Cost Basis AvailableForSaleSecuritiesAndHeldToMaturitySecuritiesAtCostBasis	1551000000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	17000000	usd
CY2023Q3	us-gaap	Short Term Investments ShortTermInvestments	1534000000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	120000000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	118000000	usd
CY2023Q4	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount	208000000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	362000000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	354000000	usd
CY2023Q4	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount	0	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	183000000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	173000000	usd
CY2023Q4	us-gaap	Held To Maturity Securities Debt Maturities After Five Through Ten Years Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount	0	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	665000000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	645000000	usd
CY2023Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	208000000	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	6972000000	usd
CY2023Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	6484000000	usd
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	26000000	usd
CY2023Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	26000000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1080000000	usd
CY2023Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	1081000000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	5866000000	usd
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	5377000000	usd
CY2023Q4	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	500000000	usd
CY2023Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	6234000000	usd
CY2023Q3	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	5738000000	usd
CY2023Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	4000000000	usd
CY2023Q4	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	3401000000	usd
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	444403000	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	444531000	shares
CY2023Q4	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	70000000	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	3045000	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	405.63
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	1573000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	544.28
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	1810000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	430.49
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	13000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	446.28
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	2795000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	467.39
CY2023Q4	us-gaap	Share Based Compensation ShareBasedCompensation	444000000	usd
CY2022Q4	us-gaap	Share Based Compensation ShareBasedCompensation	402000000	usd
CY2023Q4	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	95000000	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	89000000	usd
CY2023Q4	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	349000000	usd
CY2022Q4	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	313000000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	1589000000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	1364000000	usd
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	443827000	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	443837000	shares
CY2023Q4	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	576000	shares
CY2022Q4	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	694000	shares
CY2023Q4	us-gaap	Revenues Revenues	57799000000	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	1984000000	usd
CY2022Q4	us-gaap	Revenues Revenues	54437000000	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	1751000000	usd
CY2023	us-gaap	Revenues Revenues	242290000000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	8114000000	usd

Files In Submission

Name	View Source	Status
0000909832-23-000065-index-headers.html	Edgar Link	pending
0000909832-23-000065-index.html	Edgar Link	pending
0000909832-23-000065.txt	Edgar Link	pending
0000909832-23-000065-xbrl.zip	Edgar Link	pending
cost-20231126.htm	Edgar Link	pending
cost-20231126.xsd	Edgar Link	pending
costex10210q112623.htm	Edgar Link	pending
costex31110q112623.htm	Edgar Link	pending
costex32110q112623.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
cost-20231126_def.xml	Edgar Link	unprocessable
cost-20231126_pre.xml	Edgar Link	unprocessable
cost-20231126_cal.xml	Edgar Link	unprocessable
cost-20231126_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cost-20231126_htm.xml	Edgar Link	completed
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$COST
COSTCO WHOLESALE CORP /NEW Stock $cost

2023 Q4 Form 10-Q Financial Statement

#000090983223000065 Filed on December 20, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$COST COSTCO WHOLESALE CORP /NEW Stock $cost

2023 Q4 Form 10-Q Financial Statement

#000090983223000065 Filed on December 20, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$COST
COSTCO WHOLESALE CORP /NEW Stock $cost